University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Items where Author is "Halloran, S"

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Number of items: 71.

Article

Bonello, B, Ghanouni, A, Bowyer, HL, MacRae, E, Atkin, W, Halloran, SP, Wardle, J and von Wagner, C (2016) Using a hypothetical scenario to assess public preferences for colorectal surveillance following screening-detected, intermediate-risk adenomas: annual home-based stool test vs. triennial colonoscopy BMC GASTROENTEROLOGY, 16, ARTN 113.

Cooper, JA, Moss, SM, Smith, S, Seaman, HE, Taylor-Phillips, S, Parsons, N and Halloran, SP (2016) FIT for the future: a case for risk-based colorectal cancer screening using the faecal immunochemical test COLORECTAL DISEASE, 18 (7). pp. 650-653.

Young, GP, Senore, C, Mandel, JS, Allison, JE, Atkin, WS, Benamouzig, R, Bossuyt, PMM, Silva, MD, Guittet, L, Halloran, SP, Haug, U, Hoff, G, Itzkowitz, SH, Leja, M, Levin, B, Meijer, GA, O'Morain, CA, Parry, S, Rabeneck, L, Rozen, P, Saito, H, Schoen, RE, Seaman, HE, Steele, RJC, Sung, JJY and Winawer, SJ (2016) Recommendations for a step-wise comparative approach to the evaluation of new screening tests for colorectal cancer CANCER, 122 (6). pp. 826-839.

Wardle, J, von Wagner, C, Kralj-Hans, I, Halloran, SP, Smith, SG, McGregor, LM, Vart, G, Howe, R, Snowball, J, Handley, G, Logan, RF, Rainbow, S, Smith, S, Thomas, MC, Counsell, N, Morris, S, Duffy, SW, Hackshaw, A, Moss, S, Atkin, W and Raine, R (2016) Effects of evidence-based strategies to reduce the socioeconomic gradient of uptake in the English NHS Bowel Cancer Screening Programme (ASCEND): four cluster-randomised controlled trials LANCET, 387 (10020). pp. 751-759.

Kearns, B, Whyte, S, Seaman, HE, Snowball, J, Halloran, SP, Butler, P, Patnick, J, Nickerson, C and Chilcott, J (2016) Factors associated with completion of bowel cancer screening and the potential effects of simplifying the screening test algorithm BRITISH JOURNAL OF CANCER, 114 (3). pp. 327-333.

Raine, R, Duffy, SW, Wardle, J, Solmi, F, Morris, S, Howe, R, Kralj-Hans, I, Snowball, J, Counsell, N, Moss, S, Hackshaw, A, von Wagner, C, Vart, G, McGregor, L, Smith, SG, Halloran, S, Handley, G, Logan, RF, Rainbow, S, Smith, S, Thomas, MC and Atkin, W (2016) Impact of general practice endorsement on the social gradient in uptake in bowel cancer screening BRITISH JOURNAL OF CANCER, 114 (3). pp. 321-326.

McGregor, LM, von Wagner, C, Atkin, W, Kralj-Hans, I, Halloran, SP, Handley, G, Logan, RF, Rainbow, S, Smith, S, Snowball, J, Thomas, MC, Smith, SG, Vart, G, Howe, R, Counsell, N, Hackshaw, A, Morris, S, Duffy, SW, Raine, R and Wardle, J (2016) Reducing the Social Gradient in Uptake of the NHS Colorectal Cancer Screening Programme Using a Narrative-Based Information Leaflet: A Cluster-Randomised Trial GASTROENTEROLOGY RESEARCH AND PRACTICE, ARTN 36701.

Steele, R, Forgacs, I, McCreanor, G, Benton, S, Machesney, M, Rees, C, Halloran, SP, Abulafi, M and Alsina, D (2015) SUSPECTED CANCER IN ADULTS Use of faecal occult blood tests in symptomatic patients BMJ-BRITISH MEDICAL JOURNAL, 351, ARTN h4256.

Logan, RF and Halloran, SP (2015) Comment on impact on colorectal cancer mortality of screening programmes based on the faecal immunochemical test GUT, 64 (6). pp. 1006-1007.

Young, GP, Symonds, EL, Allison, JE, Cole, SR, Fraser, CG, Halloran, SP, Kuipers, EJ and Seaman, HE (2015) Advances in Fecal Occult Blood Tests: The FIT Revolution DIGESTIVE DISEASES AND SCIENCES, 60 (3). pp. 609-622.

Benton, SC, Seaman, HE and Halloran, SP (2015) Faecal occult blood testing for colorectal cancer screening: the past or the future. Curr Gastroenterol Rep, 17 (2).

Lo, SH, Halloran, S, Snowball, J, Seaman, H, Wardle, J and von Wagner, C (2015) Predictors of repeat participation in the NHS bowel cancer screening programme BRITISH JOURNAL OF CANCER, 112 (1). pp. 199-206.

Phalguni, A, Seaman, H, Routh, K, Halloran, S and Simpson, S (2015) Tests detecting biomarkers for screening of colorectal cancer: What is on the horizon? GMS Health Technol Assess, 11.

Geraghty, J, Butler, P, Seaman, H, Snowball, J, Sarkar, S, Blanks, R, Halloran, S, Bodger, K and Rees, CJ (2014) Optimising faecal occult blood screening: retrospective analysis of NHS Bowel Cancer Screening data to improve the screening algorithm BRITISH JOURNAL OF CANCER, 111 (11). pp. 2156-2162.

Halloran, SP (2014) SCREENING Colorectal cancer screening-insights and challenges NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 11 (10). pp. 586-587.

MacRae, E, Brenner, A, Martin, J, Pearson, S, Piggott, C, Bowyer, H, Vart, G, von Wagner, C, Wardle, J, Halloran, S and Atkin, W (2014) SENSITIVITY OF ANNUAL FAECAL IMMUNOCHEMICAL TESTS FOR HAEMOGLOBIN (FIT) FOR DETECTING ADVANCED NEOPLASIA IN PATIENTS UNDERGOING THREE-YEARLY SURVEILLANCE COLONOSCOPY - THE FIT FOR FOLLOW-UP STUDY GUT, 63. A20-A21.

Allison, JE, Fraser, CG, Halloran, SP and Young, GP (2014) Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT) GUT AND LIVER, 8 (2). pp. 117-130.

Allison, JE, Fraser, CG, Halloran, SP and Young, GP (2014) Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using the fecal immunochemical test for hemoglobin (FIT). Gut Liver, 8 (2). pp. 117-130.

Allison, JE, Fraser, CG, Halloran, S and Young, GP (2014) Population screening for colorectal cancer means getting FIT: the past, present, and future of colorectal cancer screening using FIT Gut and Liver, 8. pp. 117-130.

Fraser, CG, Halloran, SP, Allison, JE and Young, GP (2013) Making colorectal cancer screening FITTER for purpose with quantitative faecal immunochemical tests for haemoglobin (FIT) CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 51 (11). pp. 2065-2067.

Fraser, CG, Allison, JE, Young, GP and Halloran, SP (2013) Quantitation of hemoglobin improves fecal immunochemical tests for noninvasive screening Clinical Gastroenterology and Hepatology, 11 (7). pp. 839-840.

von Karsa, L, Patnick, J, Segnan, N, Atkin, W, Halloran, S, Lansdorp-Vogelaar, I, Malila, N, Minozzi, S, Moss, S, Quirke, P, Steele, RJ, Vieth, M, Aabakken, L, Altenhofen, L, Ancelle-Park, R, Antoljak, N, Anttila, A, Armaroli, P, Arrossi, S, Austoker, J, Banzi, R, Bellisario, C, Blom, J, Brenner, H, Bretthauer, M, Cancela, MC, Costamagna, G, Cuzick, J, Dai, M, Daniel, J, Dekker, E, Delicata, N, Ducarroz, S, Erfkamp, H, Espinas, JA, Faivre, J, Wood, LF, Flugelman, A, Frkovic-Grazio, S, Geller, B, Giordano, L, Grazzini, G, Green, J, Hamashima, C, Herrmann, C, Hewitson, P, Hoff, G, Holten, I, Jover, R, Kaminski, MF, Kuipers, EJ, Kurtinaitis, J, Lambert, R, Launoy, G, Lee, W, Leicester, R, Leja, M, Lieberman, D, Lignini, T, Lucas, E, Lynge, E, Madai, S, Marinho, J, Zakotnik, JM, Minoli, G, Monk, C, Morais, A, Muwonge, R, Nadel, M, Neamtiu, L, Tuser, MP, Pignone, M, Pox, C, Primic-Zakelj, M, Psaila, J, Rabeneck, L, Ransohoff, D, Rasmussen, M, Regula, J, Ren, J, Rennert, G, Rey, J, Riddell, RH, Risio, M, Rodrigues, V, Saito, H, Sauvaget, C, Scharpantgen, A, Schmiegel, W, Senore, C, Siddiqi, M, Sighoko, D, Smith, R, Smith, S, Suchanek, S, Suonio, E, Tong, W, Tornberg, S, Van Cutsem, E, Vignatelli, L, Villain, P, Voti, L, Watanabe, H, Watson, J, Winawer, S, Young, G, Zaksas, V, Zappa, M and Valori, R (2013) European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication ENDOSCOPY, 45 (1). pp. 51-59.

Bowyer, HL, Vart, G, Kralj-Hans, I, Atkin, W, Halloran, SP, Seaman, H, Wardle, J and von Wagner, C (2013) Patient attitudes towards faecal immunochemical testing for haemoglobin as an alternative to colonoscopic surveillance of groups at increased risk of colorectal cancer JOURNAL OF MEDICAL SCREENING, 20 (3). pp. 149-156.

Massat, NJ, Moss, SM, Halloran, SP and Duffy, SW (2013) Screening and Primary prevention of Colorectal Cancer: a Review of sex-specific and site-specific differences JOURNAL OF MEDICAL SCREENING, 20 (3). pp. 125-148.

Watson, J, Shaw, K, MacGregor, M, Smith, S, Halloran, S, Patnick, J, Beral, V and Green, J (2013) Use of research questionnaires in the NHS Bowel Cancer Screening Programme in England: impact on screening uptake JOURNAL OF MEDICAL SCREENING, 20 (4). pp. 192-197.

Kralj-Hans, S, Martin, J, Pearson, S, Piggott, C, Bowyer, H, Vart, G, von Wagner, C, Wardle, J, Halloran, S and Atkin, W (2013) Could faecal immunochemical tests for haemoglobin (FIT) change surveillance of people with intermediate risk adenomas? Gut, 62 (Suppl ).

Geraghty, J, Snowball, J, Butler, P, Sarkar, S, Blanks, R, Halloran, S, Rutter, M and Rees, C (2013) Faecal occult blood test analysis in the United Kingdom bowel cancer screening programme. Gut, 62 (Suppl ).

Halloran, S (2013) Scientific and technical attributes supporting wide adoption of fecal immunochemical tests. Biochimica Clinica, 37 (SS).

Halloran, SP, Launoy, G and Zappa, M (2012) European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition--Faecal occult blood testing. Endoscopy, 44 Sup. SE65-SE87.

Morris, S, Baio, G, Kendall, E, von Wagner, C, Wardle, J, Atkin, W, Halloran, SP, Handley, G, Logan, RF, Obichere, A, Rainbow, S, Smith, S, Snowball, J and Raine, R (2012) Socioeconomic variation in uptake of colonoscopy following a positive faecal occult blood test result: a retrospective analysis of the NHS Bowel Cancer Screening Programme BRITISH JOURNAL OF CANCER, 107 (5). pp. 765-771.

Burtonwood, C, Butler, P, Young, M and Halloran, S (2012) MONITORING FAECAL OCCULT BLOOD TEST POSITIVITY IN THE NHS BOWEL CANCER SCREENING PROGRAMME GUT, 61. A334-A334.

Seaman, H, Young, M and Halloran, S (2012) THE NHS BOWEL CANCER SCREENING PROGRAMME, SOUTHERN HUB-SCREENING ACTIVITY AND OUTCOMES GUT, 61. A335-A335.

Snowball, J, Young, M and Halloran, S (2012) WILL THE NATIONAL AWARENESS AND EARLY DIAGNOSIS INITIATIVE (NAEDI) HAVE AN IMPACT ON BOWEL CANCER SCREENING ACTIVITY? GUT, 61. A334-A335.

Fraser, CG, Allison, JE, Young, GP and Halloran, SP (2012) Newer Fecal Tests: Opportunities for Professionals in Laboratory Medicine CLINICAL CHEMISTRY, 58 (6). pp. 963-965.

Fraser, CG, Allison, JE, Halloran, SP, Young, GP and on behalf of the Expert Working Group on Fecal Immunochemical Te, (2012) A Proposal to Standardize Reporting Units for Fecal Immunochemical Tests for Hemoglobin. J Natl Cancer Inst.

Whyte, S, Chilcott, J and Halloran, S (2012) Re-appraisal of the options for colorectal cancer screening in England. Colorectal Dis.

Allison, JE, Fraser, CG, Halloran, SP and Young, GP (2012) Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed GASTROENTEROLOGY, 142 (3). pp. 422-424.

Lo, SH, Vart, G, Snowball, J, Halloran, SP, Wardle, J and von Wagner, C (2012) The impact of media coverage of the Flexible Sigmoidoscopy Trial on English colorectal screening uptake JOURNAL OF MEDICAL SCREENING, 19 (2). pp. 83-88.

Young, GP, Fraser, CG, Halloran, SP and Cole, S (2012) Guaiac based faecal occult blood testing for colorectal cancer screening: An obsolete strategy? Gut.

Halloran, S, Snowball, J and Young, M (2012) The impact of the National Awareness and Early Diagnosis Initiative (NAEDI) – an analysis of bowel cancer screening activity during the pilot campaign. Gut, 61 (Suppl ).

Grazzini, G, Zappa, M, Ventura, L, Rubeca, T and Halloran, SP (2011) Different seasons with decreased performance of immunochemical faecal occult blood tests in colorectal cancer screening Response GUT, 60 (9). p. 1304.

Hewitson, P, Ward, AM, Heneghan, C, Halloran, SP and Mant, D (2011) Primary care endorsement letter and a patient leaflet to improve participation in colorectal cancer screening: results of a factorial randomised trial BRITISH JOURNAL OF CANCER, 105 (4). pp. 475-480.

von Wagner, C, Baio, G, Raine, R, Snowball, J, Morris, S, Atkin, W, Obichere, A, Handley, G, Logan, RF, Rainbow, S, Smith, S, Halloran, S and Wardle, J (2011) Inequalities in participation in an organized national colorectal cancer screening programme: results from the first 2.6 million invitations in England INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 40 (3). pp. 712-718.

von Wagner, C, Baio, G, Raine, R, Snowball, J, Morris, S, Atkin, W, Obichere, A, Handley, G, Logan, R, Rainbow, S, Smith, S, Halloran, S and Wardle, J (2011) DISPARITIES IN UPTAKE OF AN ORGANIZED NATIONAL COLORECTAL CANCER SCREENING PROGRAM: RESULTS FROM THE FIRST 2.6 MILLION INVITATIONS IN ENGLAND ANN BEHAV MED, 41. S6-S6.

Neale, J, Patel, P, Snowball, J and Halloran, S (2011) Diagnosis and treatment of very large polyps found within the bowel cancer screening programme: experience of practice in a large single screening centre Gut, 60 (Suppl ). A195-A196.

Grazzini, G, Zappa, M and Halloran, SP (2011) Limited effect of summer warming on the sensitivity of colorectal cancer screening Gut.

Duffy, MJ, Van Rossum, LGM, Van Turenhout, ST, Malminiemi, O, Sturgeon, C, Lamerz, R, Nicolini, A, Haglund, C, Holubec, L, Fraser, CG and Halloran, SP (2011) Use of faecal markers in screening for colorectal neoplasia: A European group on tumor markers position paper International Journal of Cancer, 128 (1). pp. 3-11.

Nnoaham, KE, Frater, A, Roderick, P, Moon, G and Halloran, S (2010) Do geodemographic typologies explain variations in uptake in colorectal cancer screening? An assessment using routine screening data in the south of England JOURNAL OF PUBLIC HEALTH, 32 (4). pp. 572-581.

Grazzini, G, Zappa, M, Ventura, L, Rubeca, T and Halloran, SP (2010) Letter Gut, 60 (3).

Grazzini, G, Ventura, L, Zappa, M, Ciatto, S, Confortini, M, Rapi, S, Rubeca, T, Visioli, CB and Halloran, SP (2010) Influence of seasonal variations in ambient temperatures on performance of immunochemical faecal occult blood test for colorectal cancer screening: observational study from the Florence district GUT, 59 (11). pp. 1511-1515.

Halloran, SP (2009) Bowel cancer screening Surgery, 27 (9). pp. 397-400.

Halloran, S, Snowball, J and Slyfield, J (2009) How good is the guaiac-based faecal occult blood test for population screening of colorectal cancer? Clinical Chemistry, 55 (6 (Sup).

Halloran, SP (2004) Urine analysis - an MHRA perspective JOURNAL OF PHARMACY AND PHARMACOLOGY, 56. S99-S99.

Sharp, S, Cummins, D, Halloran, S, Donaldson, M and Turnbull, L (2001) Explosions map occur if dry ice is placed in airtight transport containers BRITISH MEDICAL JOURNAL, 322 (7283). p. 434.

Chantler, D, Halloran, S, Domke, I and Hon, K (2000) Evaluation of acetaminophen reagent on the COBAS (R) INTEGRA 700 analyzer. CLINICAL CHEMISTRY, 46 (6). A23-A23.

Halloran, S and Bennitt, W (1999) Urine reagent strips: an MDA evaluation. Prof Nurse, 14 (11). pp. 791-796.

Hingorani, AD, OHanlon, S, Halloran, SP, Wright, JP and Foley, TH (1997) Evaluation of a paired creatine kinase test for the diagnosis of acute myocardial infarction in patients with a non-diagnostic electrocardiogram JOURNAL OF ACCIDENT & EMERGENCY MEDICINE, 14 (3). pp. 134-138.

Conference or Workshop Item

Taylor, M, Wood, HM, Halloran, S and Quirke, P (2016) Exploring the Suitability and Stability of Guaiac Faecal Occult Blood Test Cards to Isolate Microbial DNA for 16srRNA Sequencing In: 9th Joint Meeting of the British-Division of the International-Academy-of-Pathology and the Pathological-Society-of-Great-Britain-and-Ireland, 2016-06-28 - 2016-07-01, Univ Nottingham, Sch Med, Acad Univ Mol Pathol Div Canc & Stem Cells, Nottingham, ENGLAND.

Lo, SH, Ghanouni, A, Rees, C, Rutter, M, Snowball, J, Seaman, H, Halloran, S, Wardle, J and von Wagner, C (2015) COLONOSCOPY COMFORT AND SUBSEQUENT FAECAL OCCULT BLOOD SCREENING UPTAKEIN THE ENGLISH BOWEL CANCER SCREENING PROGRAMME In: 2nd Digestive-Disorders-Federation Conference, 2015-06-22 - 2015-06-25, London, ENGLAND.

MacRae, E, Marchevsky, N, Brenner, A, Patel, B, Pearson, S, Piggott, C, von Wagner, C, Wardle, J, Halloran, S and Atkin, W (2015) DETERMINING THE SENSITIVITY AND SPECIFICITY OF ANNUAL FAECAL IMMUNOCHEMICAL TESTS FOR HAEMOGLOBIN (FIT) COMPARED WITH FINDINGS AT SURVEILLANCE COLONOSCOPY FOR PATIENTS DIAGNOSED WITH INTERMEDIATE RISK ADENOMAS THE FIT FOR FOLLOW-UP STUDY In: 2nd Digestive-Disorders-Federation Conference, 2015-06-22 - 2015-06-25, London, ENGLAND.

Moss, S, Mathews, C, Day, T, Smith, S and Halloran, SP (2015) INCREASED PARTICIPATION IN COLORECTAL CANCER SCREENING DURING A PILOT OF FAECAL IMMUNOCHEMICAL TEST FOR HAEMOGLOBIN (FIT) IN ENGLAND In: 2nd Digestive-Disorders-Federation Conference, 2015-06-22 - 2015-06-25, London, ENGLAND.

Benton, SC, Butler, P, Reed, K, Rickard, S, Stanley, S, Chesters, M, Roope, R and Halloran, SP (2015) INCREASING UPTAKE IN THE BOWEL CANCER SCREENING PROGRAMME WITH GP PARTICIPATION: THE PEARL PROJECT In: 2nd Digestive-Disorders-Federation Conference, 2015-06-22 - 2015-06-25, London, ENGLAND.

Neale, J, Patel, P, Snowball, J and Halloran, S (2011) DIAGNOSIS AND TREATMENT OF VERY LARGE POLYPS FOUND WITHIN THE BOWEL CANCER SCREENING PROGRAMME: EXPERIENCE OF PRACTICE IN A LARGE SINGLE SCREENING CENTRE In: Annual Meeting on British-Society-of-Gasenterology, 2011-03-14 - 2011-03-17, Birmingham, ENGLAND.

Halloran, SP, Piggott, CJ and French-Mowat, E (2009) Analyser Monitoring Programme (AMP) for Automated Clinical Analysers 2008/2009 In: Annual Meeting of the American-Association-for-Clinical-Chemistry, 2009-07-19 - 2009-07-23, Chicago, IL.

Halloran, SP, Snowball, J and Slyfield, J (2009) How Good is the Guaiac-based Faecal Occult Blood Test for Population Screening? In: Annual Meeting of the American-Association-for-Clinical-Chemistry, 2009-07-19 - 2009-07-23, Chicago, IL.

French-Mowat, E, Piggott, C and Halloran, SP (2005) Analyser monitoring programme: A new venture In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

Bettany, JH and Halloran, SP (2005) Audit of demand management protocol takeup In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

Burtonwood, C, Piggott, C and Halloran, S (2005) Comparison of bayer semi-quantitative tests for microalbuminuria In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

Burtonwood, CA, Piggott, CJ and Halloran, SP (2005) Evaluation of four POCT devices for the quantitation of microalbuminuria In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

Lamph, SA, Wheeler, MJ and Halloran, SP (2005) GMEC evaluation of the TOSOH AIA (R)-1800 immunoassay analyser In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

McGuire, J, Halloran, S, Godber, I, Kay, J and Hallworth, M (2005) Lab tests online UK: How has the public reacted? In: European Congress of Clinical Biochemistry and Laboratory Medicine (EUROMEDLAB 2005), 2005-05-08 - 2005-05-12, Glasgow, SCOTLAND.

This list was generated on Mon Sep 25 10:07:15 2017 UTC.

Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800